Salivary Gland Cancer

Salivary gland cancer is a disease of a salivary gland. Currently approximately one per 100,000 people per year gets this type of cancer. The tumours in the salivary glands in three-quarters of the cases are benign tumours, and malignancies in a quarter of cases.

Referring to the saliva-secreting Parotid gland (Glandula Parotid) approximately 80 percent of tumours are benign, and 20 percent are malignant. The most common benign tumour of the salivary gland is the Pleomorphic  adenoma. The second most common benign tumour is the Warthin tumour (Zystadenolymphoma). Other benign tumours are very rare.

There are a number of subtypes of malignant tumours which are identified on the basis of their histologic features. The mucoepidermoid carcinomas, Adenoid cystic carcinoma, adenocarcinomas, the Acinus Carcinoma, Squamous Cell Carcinoma, metastases of other tumours in the area of the salivary glands, are the most common tumours in addition to a number of rare malignant tumours.

Malignant tumours of the salivary glands must be taken very seriously since these tumours frequently lead to the settlement of metastases in the soft tissues of the neck.

A functional check of the facial nerves and scanning the area are the first steps to diagnosis, which must be confirmed with an ultrasound. A biopsy is not always an accurate assessment. A differential diagnosis to identify non-epithelial malignancies, benign tumours, and the metastases of other primary tumours is needed in order to clarify the diagnosis.

Recommended therapies for the treatment of salivary gland cancer:

Find answers to your questions.

Read the book

"Innovation in biological Cancer Therapy"

in the Second Edition

by Dr. Peter Wolf.

Simply fill out the form and we will reply with an offer including a time schedule.